TNFRSF11B and cancer: While low and intermediate expression of osteoprotegerin by cancer cells correlates with an increase in osteolysis and hence tumor burden, at high OPG expression, the remodeling front is too small to completely resorb all bone tissue, leading to an overall decrease in tumor mass.